Targeting Potential of Zinc Oxide Nanoparticles and Finasteride-Loaded Nano Lipidic Carriers-Infused Topical Gel - In Vitro and In Vivo Skin Permeation Studies

The document discusses a study on the use of Finasteride (FIN), an inhibitor of the 5α reductase enzyme, in a topical gel form for treating androgenic alopecia. The study explores the use of lipidic nanocarriers to improve follicular permeability and solubility. The document suggests that these nanocarriers could potentially offer numerous benefits, including reducing the severe systemic adverse effects associated with oral treatments for androgenic alopecia. However, the document does not provide specific data or results from the study.